HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs.

Abstract
The gastrin-releasing peptide receptor (GRPR) is overexpressed in a variety of human malignancies, including prostate cancer. Bombesin (BBN) is a 14 amino acids peptide that selectively binds to GRPR. In this study, we developed two novel Al(18)F-labeled lanthionine-stabilized BBN analogs, designated Al(18)F-NOTA-4,7-lanthionine-BBN and Al(18)F-NOTA-2,6-lanthionine-BBN, for positron emission tomography (PET) imaging of GRPR expression using xenograft prostate cancer models. (Methyl)lanthionine-stabilized 4,7-lanthionine-BBN and 2,6-lanthionine-BBN analogs were conjugated with a NOTA chelator and radiolabeled with Al(18)F using the aluminum fluoride strategy. Al(18)F-NOTA-4,7-lanthionine-BBN and Al(18)F-NOTA-2,6-lanthionine-BBN was labeled with Al(18)F with good radiochemical yield and specific activity>30 GBq/μmol for both radiotracers. The logD values measured for Al(18)F-NOTA-4,7-lanthionine-BBN and Al(18)F-NOTA-2,6-lanthionine-BBN were -2.14 ± 0.14 and -2.34 ± 0.15, respectively. In athymic nude PC-3 xenografts, at 120 min post injection (p.i.), the uptake of Al(18)F-NOTA-4,7-lanthionine-BBN and Al(18)F-NOTA-2,6-lanthionine-BBN in prostate cancer (PC-3) mouse models was 0.82 ± 0.23% ID/g and 1.40 ± 0.81% ID/g, respectively. An excess of unlabeled ɛ-aminocaproic acid-BBN(7-14) (300-fold) was co-injected to assess GRPR binding specificity. Tumor uptake of Al(18)F-NOTA-4,7-lanthionine-BBN and Al(18)F-NOTA-2,6-lanthionine-BBN in PC-3 tumors was evaluated by microPET (μPET) imaging at 30, 60 and 120 min p.i. Blocking studies showed decreased uptake in PC-3 bearing mice. Stabilized 4,7-lanthionine-BBN and 2,6-lanthionine-BBN peptides were rapidly and successfully labeled with (18)F. Both tracers may have potential for GRPR-positive tumor imaging.
AuthorsG Carlucci, A Kuipers, H J K Ananias, D de Paula Faria, R A J O Dierckx, W Helfrich, R Rink, G N Moll, I J de Jong, P H Elsinga
JournalPeptides (Peptides) Vol. 67 Pg. 45-54 (May 2015) ISSN: 1873-5169 [Electronic] United States
PMID25797109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Receptors, Bombesin
  • Sulfides
  • lanthionine
  • Alanine
  • Bombesin
Topics
  • Alanine (analogs & derivatives, pharmacokinetics)
  • Animals
  • Bombesin (pharmacokinetics)
  • Cell Line, Tumor
  • Fluorine Radioisotopes (pharmacokinetics)
  • Humans
  • Male
  • Mice, Nude
  • Neoplasm Transplantation
  • Positron-Emission Tomography
  • Prostatic Neoplasms (diagnostic imaging, metabolism)
  • Radiopharmaceuticals (pharmacokinetics)
  • Receptors, Bombesin (metabolism)
  • Sulfides (pharmacokinetics)
  • Tissue Distribution
  • X-Ray Microtomography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: